Supplement × Prescription·a caution·Moderate evidence

Oxcarbazepine + St. John's Wort

Caution Moderate evidence

St. John's Wort is an inducer of CYP3A4 and P-glycoprotein. Oxcarbazepine also induces CYP3A4, so the combination can amplify interaction burden for other medications.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Caution
Evidence
Moderate
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
CautionModerate evidence

What is happening. St. John's Wort is an inducer of CYP3A4 and P-glycoprotein. Oxcarbazepine also induces CYP3A4, so the combination can amplify interaction burden for other medications.

Mechanism. Additive enzyme and transporter induction can lower exposure to susceptible co-medications.

Recommendation. Avoid unless the clinician has reviewed all medications, especially hormonal contraceptives, anticoagulants, immunosuppressants, and psychiatric drugs.

Stack Score

How it moves the number.

Effect on the composite score

If both Oxcarbazepine and St. John's Wort are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1U.S. National Library of Medicine. Oxcarbazepine tablets US Prescribing Information. 2026.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.